Vaccines are an important part of routine healthcare for adults, seniors and women who are pregnant. Older adults and seniors need protection against infectious illnesses just like children do. Dr. Cathleen Veach lists the four most important vaccines for adults.
Get the latest on Zika in the Zika Virus News Source
Recognizing a critical need to improve national vaccination rates for the human papillomavirus (HPV), Yale Cancer Center has again united with each of the 69 National Cancer Institute (NCI)-designated cancer centers in issuing a joint statement in support of recently revised recommendations from the Centers for Disease Control and Prevention (CDC).
Every year in India, about 20,000 people die from rabies. Most of the victims are children. Nearly all of the deaths occur after victims are bitten by rabid dogs. For years, experts have debated the best strategy to reduce this burden. Now, a new study has identified a cost-effective way to reduce death due to rabies.
Mayo Clinic Cancer Center today joined with 69 National Cancer Institute-designated cancer centers in issuing a joint statement supporting updated HPV vaccination guidelines from the Centers for Disease Control and Prevention (CDC).
More than a decade after the HPV vaccine was deemed both safe and effective by the FDA for preventing several types of cancer, the vaccine is still underused by those who could benefit.
Perlmutter Cancer Center at NYU Langone Medical Center is again joining with each of the 69 National Cancer Institute (NCI)-designated cancer centers in issuing a joint statement to increase vaccination against the human papillomavirus (HPV).
As national vaccination rates for the human papillomavirus (HPV) remain low, The University of Texas MD Anderson Cancer Center has again united with the 68 other National Cancer Institute (NCI)-designated cancer centers in issuing a joint statement endorsing the recently revised vaccination recommendations from the Centers for Disease Control and Prevention (CDC).
Immunotherapy is a fast growing area of cancer research. It involves developing therapies that use a patient’s own immune system to fight and kill cancer. Moffitt Cancer Center is working on a new vaccine that would help early-stage breast cancer patients who have HER2 positive disease.
An international group of researchers associated with the World Health Organization has published its final report on the Ebola vaccine trial in Guinea, finding that the vaccine is a safe and effective way to prevent Ebola infection.
An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to a new study that included researchers from the University of Maryland School of Medicine.
A new study led by scientists at The Scripps Research Institute (TSRI) is the first to show exactly how the drug Arbidol stops influenza infections. The research reveals that Arbidol stops the virus from entering host cells by binding within a recessed pocket on the virus.
Researchers at the Icahn School of Medicine at Mount Sinai are working on the basic science that lays the groundwork to finding a way to treat and prevent the Zika virus, a global health risk.
City of Hope patient Susan Young has had a remarkable response to a potentially revolutionary new treatment, a combination of the p53 cancer vaccine and a drug that blocks a specific cancer-aiding protein.
In a bid to better understand the gene expression patterns that control T cell activity, researchers at the La Jolla Institute for Allergy and Immunology mapped genome-wide changes in chromatin accessibility as T cells respond to acute and chronic virus infections.
As scientists race to create a vaccine for the Zika virus, new research from the University of Georgia suggests almost half of Americans wouldn’t be interested in getting the shot even if public health officials recommended it for them.
New genetic research from an international team including McMaster University, University of Helsinki, Vilnius University and the University of Sydney, suggests that smallpox, a pathogen that caused millions of deaths worldwide, may not be an ancient disease but a much more modern killer that went on to become the first human disease eradicated by vaccination.
A personalized cancer vaccine markedly improved outcomes for patients suffering from acute myeloid leukemia (AML), a potentially lethal blood cancer, in a clinical trial led by investigators at Beth Israel Deaconess Medical Center (BIDMC). The product of a long-term collaboration among investigators at the Cancer Center at BIDMC and Dana-Farber Cancer Institute, the vaccine stimulated powerful immune responses against AML cells and resulted in protection from relapse in a majority of patients, the team of researchers reported today in Science Translational Medicine.
In a new study, researchers have modified a rabies virus, so that it has a protein from the MERS virus; this altered virus works as a 2-for-1 vaccine that protects mice against both Middle East Respiratory Syndrome (MERS) and rabies.
A team of researchers led by Yoshihiro Kawaoka, professor of pathobiological sciences at the University of Wisconsin–Madison School of Veterinary Medicine, has developed technology that could improve the production of vaccines that protect people from influenza B.
Americans are split on getting an annual flu shot, with four out of 10 having done so in the past year and around half saying they had already received or were planning to get the vaccine this year, according to new national survey data analyzed by University of Georgia researchers.
Flu cases are being reported in Maryland and across the country, and experts at the Johns Hopkins University School of Medicine expect to see numbers continue to rise. To prevent the flu, Johns Hopkins experts say everyone 6 months and older should get vaccinated against the influenza virus every year.
New collaboration between two nonprofits focused on cancer immunotherapy aims to identify new DNA-based targets for personalized cancer treatments
Scientists at The Scripps Research Institute (TSRI) have developed a vaccine that blocks the pain-numbing effects of the opioid drugs oxycodone (oxy) and hydrocodone (hydro) in animal models.
The Wistar Institute and Man’s Best Friend Therapeutics are pleased to announce a new collaboration that leverages Wistar’s groundbreaking vaccine research and development with MBFT’s expertise in developing animal health products.
The American Association of Pharmaceutical Scientists (AAPS) is pleased to announce the elevation of nine recipients to Fellow, one of the highest honors given to members of the association. Each year, AAPS elevates a few members to Fellow in recognition of their professional excellence in fields relevant to AAPS’s mission: to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health.
Typhoid fever remains a serious global problem: it kills almost a quarter of a million people annually. To help promote typhoid vaccines, the Bill & Melinda Gates Foundation has given a $36.9 million grant to the University of Maryland School of Medicine Center for Vaccine Development (CVD). The project is a partnership with the Oxford Vaccine Group and PATH.
A study led by researchers at Beth Israel Deaconess Medical Center (BIDMC), in collaboration with scientists at Walter Reed Army Institute of Research (WRAIR), Janssen Vaccines & Prevention B.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson and Gilead Sciences, Inc., has demonstrated that combining an experimental vaccine with an innate immune stimulant may help lead to viral remission in people living with HIV. In animal trials, the combination decreased levels of viral DNA in peripheral blood and lymph nodes, and improved viral suppression and delayed viral rebound following discontinuation of anti-retroviral therapy (ART). The research team’s findings appeared online today in the journal Nature.
In this preclinical study, 100 percent of the animal models were protected from Zika after vaccination followed by a challenge with the Zika virus. In addition, they were protected from degeneration in the cerebral cortex and hippocampal areas of the brain, while the other cohort showed degeneration of the brain after Zika infection.
For the first time, scientists have prevented urinary tract infections in mice by vaccinating them with tiny molecules that UTI bacteria usually use to grab iron from their host and fuel the growth of bacteria in the bladder.
Some patients with rare primary immunodeficiency disorders may be at risk for infection by rubella virus, and possibly serious skin inflammation, after receiving the rubella vaccine, usually administered as part of the measles-mumps-rubella (MMR) vaccine. Although the vaccine for rubella (German measles) has an established record of safety and effectiveness in the general population, patients with severe deficiencies in their immune defenses may be susceptible to side effects from the vaccine.
Unique technology saves life of healthy 54-year-old who nearly dies after contracting aggressive, H1N1, flu strain. A former non-believer, he now promotes regular flu shots as prevention
A new method to determine how effectively immune cells kill their targets could help personalize immune therapies.
Asthma caused by adult exposure to cockroach detritus is blocked in mice that were vaccinated as newborns with a particular bacteria, Enterobacter that expresses alpha-1,3-glucan molecules on its surface.
Despite the proven efficacy and minimal risks associated with vaccines, many American adults continue to forgo getting vaccinations, usually due to doubt of effectiveness, concerns of the safety of the vaccines, or just a lack of consistent follow-up on their personal health care needs. The result is costly health and economic losses, both to themselves and to the general public.
Th17 cells, a type of white blood cells, protects against the Trypansoma cruzi parasite, which is spread by kissing bugs and causes Chagas disease.
With the poliovirus edging closer to eradication across the globe, Southern Research’s infectious disease labs are playing a critical role in the search for a drug that could aid the ongoing worldwide polio eradication initiative and help halt the spread of the crippling disease in a future outbreak or bio-attack.
One of the challenges to understanding the concerns behind vaccine hesitancy is that very seldom are people with worries about vaccines and vaccine advocates brought together in the same space, especially online. Both groups gravitate towards internet “echo chambers,” only communicating with other likeminded individuals. In January 2016, however, Facebook co-founder Mark Zuckerberg posted a photo of himself holding his baby daughter with the caption “Doctor’s visit – time for vaccines!” With his undeniable reach and the ability of anyone to comment, the post represented a unique opportunity to analyze the language used to express pro- vaccination and anti-vaccination viewpoints and understand how people on both sides of the debate perceive the risks of vaccination.
Scientists at the University of Basel discovered a fundamental new mechanism explaining the inadequate immune defense against chronic viral infection. These results may open up new avenues for vaccine development. They have been published in the journal “Science Immunology”.
A newly published study from researchers working in collaboration with the Regenerative Bioscience Center at the University of Georgia demonstrates fetal death and brain damage in early chick embryos similar to microcephaly—a rare birth defect linked to the Zika virus.
Moon Nahm’s groundbreaking research is on the threshold of aiding researchers in producing vaccines at prices that will propel their widespread use and help protect the estimated 1.6 million children, most of them under the age of 5, who die yearly from S. pneumoniae infections.
Currently, human papillomavirus (HPV) vaccination rates remain low across the U.S., with fewer than 40% of girls and just over 21% of boys receiving the recommended vaccine series. Research from Roswell Park Cancer Institute has identified barriers that need to be overcome to improve vaccination rates, as well as possible strategies for doing so. The study has been published online ahead of print in the Journal of Cancer Education.
Trained community partners ensure follow-through on vaccination against hepatitis B virus (HBV).
It’s the drumbeat you hear every year – time to roll up your sleeve for your annual flu vaccination. But, is it really worth the effort? Does the flu vaccine really work? “In a word: Yes!” says Dr. Claudine De Dan, a Rowan Family Medicine physician and a faculty member at the Rowan University School of Osteopathic Medicine.
October marks the start of flu season. Should you get ahead of the falling temperatures and get vaccinated this year? Absolutely, says Stacey A. Gorski, PhD, a biology professor who specializes in immunology and vaccinology at University of the Sciences.“Vaccinations should help contain the spread of the disease and keep people healthy through the holiday season and throughout the winter,” said Gorski.
Two Philadelphia research institutions are marking the 10th anniversary of a vaccine against rotavirus.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right